Within the next few days, attorneys for both sides in the Vioxx litigation will sift through the hundreds of suits against Merck & Co. so a federal judge in New Orleans can choose which will be the first to go to trial. 

Besides taking care of some of the cases involving the painkiller, which Merck withdrew from the market on Sept. 30, these trials will be instructive because they will show how jurors react to the arguments they will hear, U.S. District Judge Eldon Fallon said Thursday at a monthly status conference on the litigation.

“This will give us information about all the cases,” said Philip Wittmann, spokesman for the defense attorneys. “He wants us to try cases so we can learn something.”

Wittmann said 907 federal Vioxx cases are in New Orleans and about 700 others are en route. Although they were filed nationwide, these petitions are before Fallon because he is coordinating such elements of pretrial work as gathering evidence and taking depositions. Once this phase is complete, the suits are to return to the districts where they were filed, although trials could be held in New Orleans.

At last month’s status conference, Fallon said trials may start by the end of the year. Estimates of total potential damages have ranged as high as $30 billion.

Another batch of about 2,200 suits are in state courts, Wittmann said.

Vioxx, which was an extremely popular arthritis treatment, has been blamed for a host of health problems, including fatal heart attacks and cardiovascular ailments.



We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Merck to pay $830 million to settle investors’ Vioxx...

Merck announced Friday it will pay $830 million to settle investor complaints accusing it of committing...

Merck to pay nearly $1 billion for illegal marketing...

American pharmaceutical company Merck, Sharp & Dohme has agreed to pay $950 million to resolve criminal...

Merck paying more than 3,100 vioxx death claims

Merck & Co. is paying claims by the families of more than 3,100 users of its Vioxx painkiller who...

Settlement limits insurers' claims in Vioxx deal

TRENTON, N.J. (AP) -- Former Vioxx users getting part of a $4.85 billion settlement ending most personal...

Persistence pays in Vioxx litigation

Plaintiffs get close to $5B, but Merck could have done a lot worse. Attorneys who spent nearly one year...

Merck to start Vioxx settlement payouts in August

Merck & Co. will start cutting checks for former users of its withdrawn painkiller Vioxx next month...

Excellent law firm

Beasley Allen is an excellent law firm. I highly recommend their services.

—William M.